Actively Recruiting
Secukinumab Open Label Roll-over Extension Protocol
Led by Novartis Pharmaceuticals · Updated on 2026-03-11
1000
Participants Needed
167
Research Sites
484 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment with secukinumab, and are unable to obtain the marketed secukinumab formulation.
CONDITIONS
Official Title
Secukinumab Open Label Roll-over Extension Protocol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent or assent and parental permission as required before any assessments
- Ability to communicate effectively and willingness to comply with study requirements
- Completion of treatment in a Novartis secukinumab study, or benefit from secukinumab despite early study termination for non-safety reasons
- Investigator judgment that participant is benefiting from and should continue secukinumab treatment
- Inability to obtain marketed secukinumab formulation due to local prescription or reimbursement restrictions
You will not qualify if you...
- Premature discontinuation of study treatment in the parent protocol
- Women of childbearing potential not using contraception during the entire study or as required by local guidelines
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 167 locations
1
Providence Medical Foundation
Fullerton, California, United States, 92835
Completed
2
Purushotham Akther and Roshan Kotha MD Inc
La Mesa, California, United States, 91942
Completed
3
Precn Comprehensive Clnl Rsch Solns
San Leandro, California, United States, 94578
Completed
4
Orrin Troum MD and Medical Associates
Santa Monica, California, United States, 90404
Completed
5
Inland Rheumatology Clinical Trials INC
Upland, California, United States, 91786
Completed
6
Medvin Clinical Research
Van Nuys, California, United States, 91405
Completed
7
Center for Rheumatology Research
West Hills, California, United States, 91307
Completed
8
Denver Arthritis Clinic
Denver, Colorado, United States, 80230
Completed
9
Rheumatology Associates of South Florida
Boca Raton, Florida, United States, 33486
Actively Recruiting
10
Homestead Assoc In Research Inc
Homestead, Florida, United States, 33033
Completed
11
IRIS Research and Development
Plantation, Florida, United States, 33324
Completed
12
Conquest Research
Winter Park, Florida, United States, 32789
Completed
13
FL Medical Clinic Orlando Health
Zephyrhills, Florida, United States, 33542
Actively Recruiting
14
Willow Rheumatology Wellness
Willowbrook, Illinois, United States, 60527
Completed
15
Dawes Fretzin Clinical Rea Group
Indianapolis, Indiana, United States, 46256
Completed
16
Klein and Associates
Hagerstown, Maryland, United States, 21740
Completed
17
Ahmed Arif Medical Research Center
Grand Blanc, Michigan, United States, 48439
Completed
18
Physician Research Collaboration
Lincoln, Nebraska, United States, 68516
Completed
19
Arthritis Rheumatology and Bone Disease Associates PA
Voorhees Township, New Jersey, United States, 08043
Completed
20
St Lawrence Health System
Potsdam, New York, United States, 13676
Completed
21
Oregon Health Sciences University
Portland, Oregon, United States, 97239
Completed
22
Altoona Center for Clin Res
Duncansville, Pennsylvania, United States, 16635
Active, Not Recruiting
23
West Tennessee Research Institute
Jackson, Tennessee, United States, 38305
Actively Recruiting
24
Austin Regional Clinic Rheumatology
Austin, Texas, United States, 78731
Completed
25
Southwest Rheum Rsrch LLC
Mesquite, Texas, United States, 75150
Completed
26
Accurate Clinical Research Inc
San Antonio, Texas, United States, 78229
Active, Not Recruiting
27
Overlake Arthritis and Osteoporosis
Bellevue, Washington, United States, 98004
Completed
28
Rheumatology Pulmonary Clinic
Beckley, West Virginia, United States, 25801
Completed
29
Novartis Investigative Site
Vitória, Espírito Santo, Brazil, 29055 450
Completed
30
Novartis Investigative Site
Salvador, Estado de Bahia, Brazil, 40150 150
Completed
31
Novartis Investigative Site
Juiz de Fora, Minas Gerais, Brazil, 36010 570
Completed
32
Novartis Investigative Site
São Paulo, São Paulo, Brazil, 01244-030
Completed
33
Novartis Investigative Site
São Paulo, São Paulo, Brazil, 04266 010
Completed
34
Novartis Investigative Site
Rio de Janeiro, Brazil, 20241-180
Completed
35
Novartis Investigative Site
Sao Jose Rio Preto, Brazil, 15090 000
Completed
36
Novartis Investigative Site
Pleven, Bulgaria, 5800
Active, Not Recruiting
37
Novartis Investigative Site
Plovdiv, Bulgaria, 4002
Completed
38
Novartis Investigative Site
Sofia, Bulgaria, 1407
Active, Not Recruiting
39
Novartis Investigative Site
Sofia, Bulgaria, 1431
Completed
40
Novartis Investigative Site
Sofia, Bulgaria, 1784
Completed
41
Novartis Investigative Site
Stara Zagora, Bulgaria, 6000
Active, Not Recruiting
42
Novartis Investigative Site
Hefei, Anhui, China, 230001
Active, Not Recruiting
43
Novartis Investigative Site
Hefei, Anhui, China, 230601
Active, Not Recruiting
44
Novartis Investigative Site
Beijing, Beijing Municipality, China, 100044
Active, Not Recruiting
45
Novartis Investigative Site
Chongqing, Chongqing Municipality, China, 400010
Completed
46
Novartis Investigative Site
Xiamen, Fujian, China, 361001
Active, Not Recruiting
47
Novartis Investigative Site
Guangzhou, Guangdong, China, 510030
Completed
48
Novartis Investigative Site
Guangzhou, Guangdong, China, 510120
Completed
49
Novartis Investigative Site
Guangzhou, Guangdong, China, 510515
Active, Not Recruiting
50
Novartis Investigative Site
Shantou, Guangdong, China, 515000
Active, Not Recruiting
51
Novartis Investigative Site
Shenzhen, Guangdong, China, 518020
Active, Not Recruiting
52
Novartis Investigative Site
Wuhan, Hubei, China, 430030
Active, Not Recruiting
53
Novartis Investigative Site
Changsha, Hunan, China, 410011
Active, Not Recruiting
54
Novartis Investigative Site
Zhuzhou, Hunan, China, 412000
Completed
55
Novartis Investigative Site
Baotou, Inner Mongolia, China, 014010
Active, Not Recruiting
56
Novartis Investigative Site
Hohhot, Inner Mongolia, China, 010050
Completed
57
Novartis Investigative Site
Nanjing, Jiangsu, China, 210008
Active, Not Recruiting
58
Novartis Investigative Site
Nanjing, Jiangsu, China, 210009
Active, Not Recruiting
59
Novartis Investigative Site
Yangzhou, Jiangsu, China, 225001
Active, Not Recruiting
60
Novartis Investigative Site
Nanchang, Jiangxi, China, 330006
Active, Not Recruiting
61
Novartis Investigative Site
Pingxiang, Jiangxi, China, 337000
Active, Not Recruiting
62
Novartis Investigative Site
Changchun, Jilin, China, 130021
Active, Not Recruiting
63
Novartis Investigative Site
Linyi, Shandong, China, 276000
Active, Not Recruiting
64
Novartis Investigative Site
Chengdu, Sichuan, China, 610041
Completed
65
Novartis Investigative Site
Ürümqi, Xinjiang, China, 830001
Active, Not Recruiting
66
Novartis Investigative Site
Kunming, Yunnan, China, 650000
Active, Not Recruiting
67
Novartis Investigative Site
Ningbo, Zhejiang, China, 315016
Active, Not Recruiting
68
Novartis Investigative Site
Wenzhou, Zhejiang, China, 325000
Active, Not Recruiting
69
Novartis Investigative Site
Beijing, China, 100000
Active, Not Recruiting
70
Novartis Investigative Site
Beijing, China, 100050
Completed
71
Novartis Investigative Site
Beijing, China, 100730
Active, Not Recruiting
72
Novartis Investigative Site
Bengbu, China, 233004
Active, Not Recruiting
73
Novartis Investigative Site
Jinan, China, 250012
Completed
74
Novartis Investigative Site
Shanghai, China, 200040
Active, Not Recruiting
75
Novartis Investigative Site
Shanghai, China, 200050
Active, Not Recruiting
76
Novartis Investigative Site
Shanghai, China, 200127
Completed
77
Novartis Investigative Site
Tianjin, China, 300052
Active, Not Recruiting
78
Novartis Investigative Site
Bogota, Cundinamarca, Colombia, 110221
Completed
79
Novartis Investigative Site
Chía, Cundinamarca, Colombia, 250001
Completed
80
Novartis Investigative Site
Bucaramanga, Santander Department, Colombia, 680003
Completed
81
Novartis Investigative Site
Ibague, Tolima Department, Colombia, 730006
Completed
82
Novartis Investigative Site
Ostrava, Czech Republic, Czechia, 772 00
Actively Recruiting
83
Novartis Investigative Site
Brno-Zidonice, CZE, Czechia, 61500
Actively Recruiting
84
Novartis Investigative Site
Prague, Prague 1, Czechia, 11000
Active, Not Recruiting
85
Novartis Investigative Site
Brno, Czechia, 625 00
Actively Recruiting
86
Novartis Investigative Site
Hradec Králové, Czechia, 500 05
Active, Not Recruiting
87
Novartis Investigative Site
Prague, Czechia, 128 00
Actively Recruiting
88
Novartis Investigative Site
Prague, Czechia, 140 59
Actively Recruiting
89
Novartis Investigative Site
Prague, Czechia, 148 00
Actively Recruiting
90
Novartis Investigative Site
Prague, Czechia, 150 06
Actively Recruiting
91
Novartis Investigative Site
Uherské Hradiště, Czechia, 686 01
Actively Recruiting
92
Novartis Investigative Site
Pátrai, Greece, 26443
Withdrawn
93
Novartis Investigative Site
Guatemala City, Guatemala, 01001
Completed
94
Novartis Investigative Site
Guatemala City, Guatemala, 01009
Completed
95
Novartis Investigative Site
Guatemala City, Guatemala, 01010
Completed
96
Novartis Investigative Site
Guatemala City, Guatemala, 01011
Completed
97
Novartis Investigative Site
Surat, Gujarat, India, 395009
Completed
98
Novartis Investigative Site
Bangalore, Karnataka, India, 560 079
Completed
99
Novartis Investigative Site
Mumbai, Maharashtra, India, 400 053
Completed
100
Novartis Investigative Site
Nashik, Maharashtra, India, 422101
Completed
101
Novartis Investigative Site
Hyderabad, Telangana, India, 500082
Completed
102
Novartis Investigative Site
New Delhi, India, 110029
Completed
103
Novartis Investigative Site
Florence, FI, Italy, 50134
Completed
104
Novartis Investigative Site
Reggio Emilia, RE, Italy, 42123
Completed
105
Novartis Investigative Site
Kuching, Sarawak, Malaysia, 93586
Completed
106
Novartis Investigative Site
Kuala Lumpur, Malaysia, 59100
Completed
107
Novartis Investigative Site
Guadalajara, Jalisco, Mexico, 44160
Completed
108
Novartis Investigative Site
Culiacan, State of Mexico, Mexico, 80000
Completed
109
Novartis Investigative Site
Metepec, State of Mexico, Mexico, 52140
Completed
110
Novartis Investigative Site
Krakow, Lesser Poland Voivodeship, Poland, 30-727
Completed
111
Novartis Investigative Site
Wroclaw, Lower Silesian Voivodeship, Poland, 52-210
Completed
112
Novartis Investigative Site
Bialystok, Poland, 15-351
Completed
113
Novartis Investigative Site
Bydgoszcz, Poland, 85-168
Actively Recruiting
114
Novartis Investigative Site
Krakow, Poland, 30-002
Actively Recruiting
115
Novartis Investigative Site
Poznan, Poland, 60-218
Completed
116
Novartis Investigative Site
Sochaczew, Poland, 96-500
Completed
117
Novartis Investigative Site
Torun, Poland, 87-100
Actively Recruiting
118
Novartis Investigative Site
Warsaw, Poland, 02-118
Completed
119
Novartis Investigative Site
Warsaw, Poland, 02-637
Completed
120
Novartis Investigative Site
Warsaw, Poland, 02-962
Completed
121
Novartis Investigative Site
Warsaw, Poland, 04-305
Completed
122
Novartis Investigative Site
Wroclaw, Poland, 53-224
Completed
123
Novartis Investigative Site
Lisbon, Portugal, 1649-035
Completed
124
Novartis Investigative Site
Barnaul, Russia, 656024
Completed
125
Novartis Investigative Site
Chelyabinsk, Russia, 454048
Active, Not Recruiting
126
Novartis Investigative Site
Kazan', Russia, 420012
Completed
127
Novartis Investigative Site
Kazan', Russia, 420064
Completed
128
Novartis Investigative Site
Kemerovo, Russia, 650029
Completed
129
Novartis Investigative Site
Kemerovo, Russia, 650070
Completed
130
Novartis Investigative Site
Krasnodar, Russia, 350020
Active, Not Recruiting
131
Novartis Investigative Site
Moscow, Russia, 115522
Completed
132
Novartis Investigative Site
Moscow, Russia, 119296
Completed
133
Novartis Investigative Site
Moscow, Russia, 127473
Completed
134
Novartis Investigative Site
Saint Petersburg, Russia, 190068
Completed
135
Novartis Investigative Site
Saint Petersburg, Russia, 197022
Completed
136
Novartis Investigative Site
Saint Petersburg, Russia, 197198
Completed
137
Novartis Investigative Site
Saint Petersburg, Russia, 197198
Actively Recruiting
138
Novartis Investigative Site
Saint Petersburg, Russia, 197341
Completed
139
Novartis Investigative Site
Saratov, Russia, 410053
Completed
140
Novartis Investigative Site
Smolensk, Russia, 214019
Completed
141
Novartis Investigative Site
Ulyanovsk, Russia, 432063
Completed
142
Novartis Investigative Site
Yaroslavl, Russia, 150003
Active, Not Recruiting
143
Novartis Investigative Site
Yaroslavl, Russia, 150054
Completed
144
Novartis Investigative Site
Yekaterinburg, Russia, 620023
Completed
145
Novartis Investigative Site
Yekaterinburg, Russia, 620028
Completed
146
Novartis Investigative Site
Panorama, Western Cape, South Africa, 7500
Completed
147
Novartis Investigative Site
Stellenbosch, Western Cape, South Africa, 7600
Completed
148
Novartis Investigative Site
Seoul, Korea, South Korea, 03080
Completed
149
Novartis Investigative Site
Seoul, South Korea, 06351
Completed
150
Novartis Investigative Site
Santiago Compostela, A Coruna, Spain, 15706
Active, Not Recruiting
151
Novartis Investigative Site
Málaga, Andalusia, Spain, 29009
Completed
152
Novartis Investigative Site
L'Hospitalet de Llobregat, Barcelona, Spain, 08907
Completed
153
Novartis Investigative Site
Bilbao, Bizkaia, Spain, 48013
Completed
154
Novartis Investigative Site
Santander, Cantabria, Spain, 39008
Completed
155
Novartis Investigative Site
Vigo, Pontevedra, Spain, 36214
Completed
156
Novartis Investigative Site
A Coruña, Spain, 15006
Completed
157
Novartis Investigative Site
Madrid, Spain, 28009
Actively Recruiting
158
Novartis Investigative Site
Madrid, Spain, 28009
Completed
159
Novartis Investigative Site
Madrid, Spain, 28041
Completed
160
Novartis Investigative Site
Madrid, Spain, 28046
Actively Recruiting
161
Novartis Investigative Site
Madrid, Spain, 28046
Completed
162
Novartis Investigative Site
Seville, Spain, 41009
Withdrawn
163
Novartis Investigative Site
Valencia, Spain, 46026
Active, Not Recruiting
164
Novartis Investigative Site
Valencia, Spain, 46026
Completed
165
Novartis Investigative Site
Basel, Switzerland, 4031
Active, Not Recruiting
166
Novartis Investigative Site
Bern, Switzerland, 3010
Active, Not Recruiting
167
Novartis Investigative Site
Sankt Gallen, Switzerland, 9007
Completed
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here